Det aktive stof i Thalidomide Celgene, thalidomid, menes at virke ved at blokere for udvikling af kræftceller og ved at stimulere nogle af de specialiserede celler i immunsystemet, kroppens eget forsvar, til at angribe kræftcellerne.
The active substance in Thalidomide Celgene, thalidomide, is thought to work by blocking the development of cancer cells, and by stimulating some of the specialised cells of the immune system (the body’ s defence mechanism) to attack the cancer cells.